Your browser doesn't support javascript.
loading
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
Hrusak, Ondrej; de Haas, Valerie; Stancikova, Jitka; Vakrmanova, Barbora; Janotova, Iveta; Mejstrikova, Ester; Capek, Vaclav; Trka, Jan; Zaliova, Marketa; Luks, Ales; Bleckmann, Kirsten; Möricke, Anja; Irving, Julie; Konatkowska, Benigna; Alexander, Thomas B; Inaba, Hiroto; Schmiegelow, Kjeld; Stokley, Simone; Zemanova, Zuzana; Moorman, Anthony V; Rossi, Jorge Gabriel; Felice, Maria Sara; Dalla-Pozza, Luciano; Morales, Jessa; Dworzak, Michael; Buldini, Barbara; Basso, Giuseppe; Campbell, Myriam; Cabrera, Maria Elena; Marinov, Neda; Elitzur, Sarah; Izraeli, Shai; Luria, Drorit; Feuerstein, Tamar; Kolenova, Alexandra; Svec, Peter; Kreminska, Olena; Rabin, Karen R; Polychronopoulou, Sophia; da Costa, Elaine; Marquart, Hanne Vibeke; Kattamis, Antonis; Ratei, Richard; Reinhardt, Dirk; Choi, John K; Schrappe, Martin; Stary, Jan.
Afiliação
  • Hrusak O; Childhood Leukemia Investigation Prague, Prague, Czech Republic.
  • de Haas V; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Stancikova J; Dutch Childhood Oncology Group, The Hague, The Netherlands.
  • Vakrmanova B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Janotova I; Childhood Leukemia Investigation Prague, Prague, Czech Republic.
  • Mejstrikova E; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Capek V; Childhood Leukemia Investigation Prague, Prague, Czech Republic.
  • Trka J; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Zaliova M; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Luks A; Childhood Leukemia Investigation Prague, Prague, Czech Republic.
  • Bleckmann K; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Möricke A; Bioinformatics Centre, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Irving J; Childhood Leukemia Investigation Prague, Prague, Czech Republic.
  • Konatkowska B; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Alexander TB; Childhood Leukemia Investigation Prague, Prague, Czech Republic.
  • Inaba H; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Schmiegelow K; Department of Pediatric Hematology/Oncology, Charles University, Second Faculty of Medicine, Hospital Motol, Prague, Czech Republic.
  • Stokley S; University Medical Center, Christian Albrechts University Kiel, Kiel, Germany.
  • Zemanova Z; Department of Pediatrics, University Medical Center Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Moorman AV; University Medical Center, Christian Albrechts University Kiel, Kiel, Germany.
  • Rossi JG; Department of Pediatrics, University Medical Center Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Felice MS; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Dalla-Pozza L; Department of Pediatric Hematology, Oncology and Transplantology, University of Medical Sciences, Poznan, Poland.
  • Morales J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Dworzak M; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Buldini B; Nordic Society for Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, The Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Basso G; Institute of Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Campbell M; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Cabrera ME; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Marinov N; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Elitzur S; Immunology and Rheumatology and.
  • Izraeli S; Hematology and Oncology, Hospital Nacional de Pediatría Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina.
  • Luria D; Sydney Children's Hospital Network, Westmead, NSW, Australia.
  • Feuerstein T; Sydney Children's Hospital Network, Westmead, NSW, Australia.
  • Kolenova A; Department of Pediatrics, Medical University of Vienna, St. Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria.
  • Svec P; Laboratory of Pediatric Oncohematology, Department of Woman's and Child's Health, University of Padova, Padova, Italy.
  • Kreminska O; Laboratory of Pediatric Oncohematology, Department of Woman's and Child's Health, University of Padova, Padova, Italy.
  • Rabin KR; National Program for Antineoplastic Drugs for Children (PINDA), Chilean National Pediatric Oncology Group, Hospital Roberto del Rio/Universidad de Chile, Santiago, Chile.
  • Polychronopoulou S; Hospital del Salvador, Universidad de Chile, Santiago, Chile.
  • da Costa E; National Program for Antineoplastic Drugs for Children (PINDA), Chilean National Pediatric Oncology Group, Hospital Roberto del Rio/Universidad de Chile, Santiago, Chile.
  • Marquart HV; Hospital del Salvador, Universidad de Chile, Santiago, Chile.
  • Kattamis A; National Program for Antineoplastic Drugs for Children (PINDA), Chilean National Pediatric Oncology Group, Hospital Roberto del Rio/Universidad de Chile, Santiago, Chile.
  • Ratei R; Hospital del Salvador, Universidad de Chile, Santiago, Chile.
  • Reinhardt D; Pediatric Hematology Oncology, Schneider Children's Medical Center, Petah-Tikva, Israel.
  • Choi JK; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Schrappe M; Pediatric Hematology Oncology, Schneider Children's Medical Center, Petah-Tikva, Israel.
  • Stary J; Pediatric Hematology Oncology, Schneider Children's Medical Center, Petah-Tikva, Israel.
Blood ; 132(3): 264-276, 2018 07 19.
Article em En | MEDLINE | ID: mdl-29720486

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2018 Tipo de documento: Article